Blueprint Medicines
Price & Volume
Stats
See more52W Range | $67-$121.90 |
Market Cap | $5.9B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $434.4M |
Revenue Growth (YoY) | 126.6% |
Gross Profit (12 Mos) | $177.2M |
Diluted EPS | -$2.09 |
News
See moreYahoo Finance • 7 months ago
Blueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
Yahoo Finance • 8 months ago
30 Biggest Biotechnology Companies in the World
Yahoo Finance • 9 months ago
Blueprint Medicines Highlights AYVAKIT® (avapritinib) Long-Term Efficacy and Safety Data and Advances in Mast Cell Disease Research at 2024 AAAAI Annual Meeting
Yahoo Finance • 9 months ago
Blueprint Medicines Full Year 2023 Earnings: Beats Expectations
About
CEO | Ms. Kathryn Haviland M.B.A. |
Address | 45 Sidney Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 638 |
